Alexion Pharmaceuticals, Inc. Tech Stack
Rare disease biotech pipeline with global clinical and commercial ops
Alexion is a Boston-headquartered biotech firm owned by AstraZeneca, focused on rare disease drug discovery and commercialization across complement inhibition, metabolic disorders, and neurology. The tech stack reveals a pharma-grade data and compliance infrastructure: SAS, Medidata, CDISC SDTM, Oracle, SAP, and Power BI form the backbone of clinical trials, regulatory, and analytics work. Active adoption of SAP S/4HANA, RPA, and LangChain suggests a push toward supply-chain automation and data-driven decision-making, while hiring is weighted toward healthcare operations, clinical research, and data roles—a profile consistent with scaled clinical trial execution and real-world evidence generation.
Tech Stack 76 technologies
What Alexion Pharmaceuticals, Inc. Is Building
◆Challenges
- Ensuring compliance with safety regulations
- Audit readiness
- Increase disease awareness
- Hospital funding processes
- Managing enrollment milestones
- Process improvement for rare disease therapy
- Improving legal operations efficiency
- Integrating diverse data sources
- Improve patient identification
- Blocking issues in supply chain
▲Active Projects
- Business plan development
- Data quality and master data management initiatives
- Patient-centric partnership model implementation
- Annual enterprise strategy development
- Indication research platform
- Clinical study feasibility and implementation support
- Safety & strategy management team implementation
- Safety surveillance team implementation
- Value stream management
- Clinical study execution
Hiring Activity
Department
Seniority
Notable leadership hires: Data Capability Lead, Key Customer Lead, Launch Planning Lead, Safety Program Lead, Medical Director
